When the COVID-19 pandemic hit in March 2020, we listened to the challenges and concerns of our clients. In response, we launched a comprehensive solution to ensure that their workplaces were COVID-19 safe.
Safeguard your workforce while maintaining productivity.
Our COVID-19 solution integrates guidelines from both the CDC and OSHA into an overall workplace surveillance and response plan to limit the possibility of workplace COVID-19 transmission among workers. Our COVID-19 solution integrates with your existing health and safety protocols.
Our team, led by pandemic response expert, Dr. William Lang, has created this program to keep your employees safe and healthy while ensuring maximum efficiency.
The Benefits of our COVID-19 Program
Lower risk of transmission among employees
Day-to-day operational stability
Reduced workforce downtime
Confident, more engaged workforce
Diminished COVID-related claims
Decreased risk of litigation
The positive impact of our pandemic safety program is clear.
of employees screened daily
managed potential exposures
man-days of work saved (so far!)
Cathy Engelbert, Commissioner, WNBA
“In order to pull off a successful WNBA season amid the COVID-19 pandemic where we had the entire league at a single location, we knew it would take a great medical partner to ensure that our priority of keeping all involved healthy and safe was not only met, but exceeded the expectations of multiple stakeholders (players, coaches, athletic trainers, team physicians, and team and league staff). The medical professionals from JobSiteCare, from the medical director, the sports medicine physicians and registered nurses on site, to round the clock consultation resources, including infectious disease specialists, put in countless hours, hard work and diligence to keep the WNBA family on site at IMG Academy healthy and safe. Whenever we needed them, 24/7, they were there to help us manage the complexities of the medical needs for an entire league during a highly competitive season. We could not have completed our successful season without their services and support, and we are so grateful to them for being true MVPs of the 2020 WNBA season.”
COVID-19 Blog & Updates
The CDC has acknowledged the effectiveness of the vaccines in preventing both infections and disease in their mitigation recommendations.
By the end of April, it is likely that we will have between 200 and 250 million people with significant immunity.
We have not seen the predicted 4th wave in March, what we have seen is a flattening of what had been a steep decline in the number of cases.
In the United States, COVID-19 case rates continue to decrease although not as deeply as in recent previous weeks.
It appears that the pace of vaccination and the movement towards herd immunity has blunted the effect of more virulent variants.
The most important news on vaccines is the approval and release of the Johnson & Johnson single-dose vaccine for COVID-19.
In the past week, cases in the United States have declined by 20% and are now down to levels not seen since mid-October.
In the United States, about 12% of the population have had at least one dose of the Pfizer-BioNTech or the Moderna Vaccines.
In the United States, the overall rate of new COVID-19 infections decreased by nearly 1/4 in the last week.
Subscribe to Our Newsletter